What is the diagnostic algorithm for Pulmonary Embolism (PE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Algorithm for Pulmonary Embolism

The diagnostic approach for pulmonary embolism should follow a structured algorithm based on hemodynamic status, clinical probability assessment, D-dimer testing, and appropriate imaging, with CT pulmonary angiography being the first-line imaging test for most patients. 1, 2

Initial Assessment: Hemodynamic Status

The first step in the diagnostic algorithm is to determine the patient's hemodynamic status:

For Patients with Hemodynamic Instability (High-Risk PE Suspected):

  1. Bedside transthoracic echocardiography (TTE) should be performed immediately 1

    • If TTE shows right ventricular (RV) dysfunction without other obvious cause, consider PE likely
    • In critically unstable patients, echocardiographic evidence of RV dysfunction is sufficient to prompt immediate reperfusion without further testing
  2. If CT is immediately available and patient can be transported safely:

    • Proceed to CT pulmonary angiography (CTPA)
    • If CTPA confirms PE, initiate appropriate treatment
    • If CTPA is negative, search for alternative causes of shock
  3. If CT is not immediately available or patient cannot be transported:

    • Consider additional bedside tests:
      • Transoesophageal echocardiography (TOE) to visualize thrombi in pulmonary arteries
      • Compression ultrasonography (CUS) to detect DVT, which would support PE diagnosis

![Diagnostic algorithm for suspected high-risk PE with hemodynamic instability]

For Hemodynamically Stable Patients (Non-High-Risk PE Suspected):

Step 1: Clinical Probability Assessment

Use validated clinical prediction rules to assess pre-test probability:

  • Wells Score or Revised Geneva Score 1, 2
  • Can be used as three-level (low/intermediate/high) or two-level (PE-unlikely/PE-likely) classification

Revised Geneva Score components:

  • Previous PE or DVT: 3 points (original) or 1 point (simplified)
  • Heart rate 75-94 bpm: 3 points (original) or 1 point (simplified)
  • Heart rate ≥95 bpm: 5 points (original) or 2 points (simplified)
  • Surgery or fracture within past month: 2 points (original) or 1 point (simplified)
  • Hemoptysis: 2 points (original) or 1 point (simplified)
  • Active cancer: 2 points (original) or 1 point (simplified)
  • Unilateral lower-limb pain: 3 points (original) or 1 point (simplified)
  • Pain on lower-limb deep venous palpation and unilateral edema: 4 points (original) or 1 point (simplified)
  • Age >65 years: 1 point (both versions)

Step 2: D-dimer Testing

  • For low or intermediate clinical probability (or PE-unlikely):

    • Perform D-dimer testing
    • Use age-adjusted D-dimer cutoff for patients >50 years (age × 10 ng/mL) to improve specificity 1, 2
    • If D-dimer is negative, PE can be safely excluded (3-month thromboembolic risk <1%) 1
    • If D-dimer is positive, proceed to imaging
  • For high clinical probability (or PE-likely):

    • D-dimer testing is not recommended due to low negative predictive value
    • Proceed directly to imaging 1
  • Alternative D-dimer approach (YEARS algorithm): 1

    • For patients with no YEARS items (signs of DVT, hemoptysis, PE most likely diagnosis): PE excluded if D-dimer <1000 ng/mL
    • For patients with ≥1 YEARS item: PE excluded if D-dimer <500 ng/mL

Step 3: Imaging

  • First-line imaging: CT Pulmonary Angiography (CTPA) 1

    • Allows visualization of pulmonary arteries down to subsegmental level
    • Sensitivity 83%, specificity 96%
    • A negative CTPA adequately excludes PE in patients with low/intermediate clinical probability
    • If CTPA positive, treat for PE
  • When CTPA is contraindicated or unavailable:

    • Ventilation/perfusion (V/Q) lung scintigraphy or V/Q SPECT
    • Lower limb compression ultrasonography (CUS) to detect DVT
  • Special considerations:

    • For patients with high clinical probability and negative CTPA, consider further testing
    • For pregnant patients, both CTPA and V/Q scan can be used safely with appropriate protocols 2

![Diagnostic algorithm for suspected PE without hemodynamic instability]

Common Pitfalls to Avoid

  1. Failing to assess clinical probability before ordering tests, which should guide the diagnostic approach 1

  2. Inappropriate use of D-dimer testing:

    • Using D-dimer in high clinical probability patients
    • Not using age-adjusted cutoffs in elderly patients
    • Relying on point-of-care D-dimer tests which have lower sensitivity (88% vs. 95% for laboratory tests) 1
  3. Misinterpreting single subsegmental PE on CTPA, which may be a false positive 2

  4. Delaying anticoagulation in patients with high clinical probability while awaiting confirmatory tests 2

  5. Overreliance on clinical signs and symptoms alone, which are often nonspecific (chest pain, dyspnea, tachycardia) 1

  6. Misinterpreting normal oxygen saturation as ruling out PE (up to 40% of PE patients have normal SaO2) 1

  7. Not considering PE in pregnant patients due to concern about radiation exposure 2

By following this structured diagnostic algorithm, clinicians can effectively diagnose or exclude PE while minimizing unnecessary testing and treatment delays that could impact patient mortality and morbidity.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pulmonary Embolism Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.